AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MEDICA GROUP PLC

Remuneration Information Apr 16, 2020

4972_dirs_2020-04-16_99e9f794-71d2-49e1-b390-25a957adc4d6.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9341J

Medica Group PLC

16 April 2020

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 15 April 2020, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:

Name of PDMR Number of shares subject to option
Stuart Quin 615,385
Dr Stephen Davies 180,995
Kevin Terrins 117,647
Sarah Burns 117,647
Marc O'Brien 162,896

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, and set out more details of the transactions.

1. Details of PDMR
(a) Name 1.           Stuart Quin

2.           Dr Stephen Davies

3.           Kevin Terrins

4.           Sarah Burns

5.           Marc O'Brien
2. Reason for notification
(b) Position / status 1.           Chief Executive Officer

2.           Medical Director and Responsible Officer

3.           Business Development Director

4.           Chief Operating Officer

5.           Chief Technical Officer
(c) Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017
(c) Price(s) and volume Option Price nil in each case

1.           615,385

2.           180,995

3.           117,647

4.           117,647

5.           162,896
(d) Aggregated information N/A
(e) Date of the transaction 15 April 2020
(f) Place of the transaction Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHKKABNQBKDKQD

Talk to a Data Expert

Have a question? We'll get back to you promptly.